Alison Bauerlein - May 9, 2023 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Signature
/s/ Jeremy Hayden, Attorney-in-Fact for Alison Bauerlein
Stock symbol
SGHT
Transactions as of
May 9, 2023
Transactions value $
$0
Form type
4
Date filed
5/11/2023, 09:55 PM
Previous filing
Apr 5, 2023
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGHT Common Stock Award $0 +103K $0.00* 0 May 9, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGHT Stock Option (Right to Buy) Award $0 +71.8K $0.00 71.8K May 9, 2023 Common Stock 71.8K $10.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments commencing May 15, 2024 and continuing through May 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share. The RSUs have no expiration date.
F2 Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable as to 25% of the underlying shares on April 3, 2024, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options shall be fully vested and exercisable on April 3, 2027.

Remarks:

Chief Financial Officer and Treasurer